These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Chemokines in the melanoma metastasis biomarkers portrait. Neagu M; Constantin C; Longo C J Immunoassay Immunochem; 2015; 36(6):559-66. PubMed ID: 25839711 [TBL] [Abstract][Full Text] [Related]
8. Development and Validation of Tumor Immunogenicity Based Gene Signature for Skin Cancer Risk Stratification. Yavartanoo M; Yi GS Int J Mol Sci; 2021 Nov; 22(21):. PubMed ID: 34769455 [TBL] [Abstract][Full Text] [Related]
9. GLT8D1 overexpression as a novel prognostic biomarker in human cutaneous melanoma. Hu H; Li Z; Zhou Y; Zhang Y; Zhao L; Zhao W; Huang Y; Song X Melanoma Res; 2019 Dec; 29(6):612-620. PubMed ID: 31305325 [TBL] [Abstract][Full Text] [Related]
10. Current status of diagnostic and prognostic markers in melanoma. Levine D; Fisher DE Methods Mol Biol; 2014; 1102():177-97. PubMed ID: 24258980 [TBL] [Abstract][Full Text] [Related]
11. A Leukocyte Infiltration Score Defined by a Gene Signature Predicts Melanoma Patient Prognosis. Zhao Y; Schaafsma E; Gorlov IP; Hernando E; Thomas NE; Shen R; Turk MJ; Berwick M; Amos CI; Cheng C Mol Cancer Res; 2019 Jan; 17(1):109-119. PubMed ID: 30171176 [TBL] [Abstract][Full Text] [Related]
12. Predicting the clinical outcome of melanoma using an immune-related gene pairs signature. Meng L; He X; Zhang X; Zhang X; Wei Y; Wu B; Li W; Li J; Xiao Y PLoS One; 2020; 15(10):e0240331. PubMed ID: 33031392 [TBL] [Abstract][Full Text] [Related]
13. Stage-specific prognostic biomarkers in melanoma. Cheng Y; Lu J; Chen G; Ardekani GS; Rotte A; Martinka M; Xu X; McElwee KJ; Zhang G; Zhou Y Oncotarget; 2015 Feb; 6(6):4180-9. PubMed ID: 25784655 [TBL] [Abstract][Full Text] [Related]
14. Germline determinants of clinical outcome of cutaneous melanoma. Vogelsang M; Wilson M; Kirchhoff T Pigment Cell Melanoma Res; 2016 Jan; 29(1):15-26. PubMed ID: 26342156 [TBL] [Abstract][Full Text] [Related]
15. Melanoma long non-coding RNA signature predicts prognostic survival and directs clinical risk-specific treatments. Chen X; Guo W; Xu XJ; Su F; Wang Y; Zhang Y; Wang Q; Zhu L J Dermatol Sci; 2017 Mar; 85(3):226-234. PubMed ID: 27955882 [TBL] [Abstract][Full Text] [Related]
16. Loss of tumor suppressors KAI1 and p27 identifies a unique subgroup of primary melanoma patients with poor prognosis. Zhang G; Cheng Y; Chen G; Tang Y; Ardekani G; Rotte A; Martinka M; McElwee K; Xu X; Wang Q; Zhou Y Oncotarget; 2015 Sep; 6(26):23026-35. PubMed ID: 26246476 [TBL] [Abstract][Full Text] [Related]
17. Expression of miR-203 is decreased and associated with the prognosis of melanoma patients. Wang K; Zhang ZW Int J Clin Exp Pathol; 2015; 8(10):13249-54. PubMed ID: 26722525 [TBL] [Abstract][Full Text] [Related]
18. [Molecular and pathomorphological prognostic markers for melanoma: Current approaches and prospects]. Ruksha TG; Aksenenko MB; Shvetsova YI Arkh Patol; 2015; 77(4):71-77. PubMed ID: 26485783 [TBL] [Abstract][Full Text] [Related]